Skip Navigation Links.
Collapse <span class="m110 colortj mt20 fontw700">Volume 12 (2024)</span>Volume 12 (2024)
Collapse <span class="m110 colortj mt20 fontw700">Volume 11 (2023)</span>Volume 11 (2023)
Collapse <span class="m110 colortj mt20 fontw700">Volume 10 (2022)</span>Volume 10 (2022)
Collapse <span class="m110 colortj mt20 fontw700">Volume 9 (2021)</span>Volume 9 (2021)
Collapse <span class="m110 colortj mt20 fontw700">Volume 8 (2020)</span>Volume 8 (2020)
Collapse <span class="m110 colortj mt20 fontw700">Volume 7 (2019)</span>Volume 7 (2019)
Collapse <span class="m110 colortj mt20 fontw700">Volume 6 (2018)</span>Volume 6 (2018)
Collapse <span class="m110 colortj mt20 fontw700">Volume 5 (2017)</span>Volume 5 (2017)
Collapse <span class="m110 colortj mt20 fontw700">Volume 4 (2016)</span>Volume 4 (2016)
Collapse <span class="m110 colortj mt20 fontw700">Volume 3 (2015)</span>Volume 3 (2015)
Collapse <span class="m110 colortj mt20 fontw700">Volume 2 (2014)</span>Volume 2 (2014)
Collapse <span class="m110 colortj mt20 fontw700">Volume 1 (2013)</span>Volume 1 (2013)
American Journal of Public Health Research. 2023, 11(4), 143-151
DOI: 10.12691/AJPHR-11-4-3
Original Research

Status Report of National Reference Laboratories for Epidemiological Surveillance of Communicable Diseases and Diseases with Epidemic Potential in Côte d'Ivoire after More Than a Decade of Existence

Maxime Kouao Diané1, 2, , Claude Aimée Diaha-Kouamé1, 3, Rita José Julie Bouagnon1, 2, Hervé A. Kadjo1, 4, Karidja Yakoura Ouattara5, 4, Mathias Kouamé N’dri1, 6, Nathalie Aya Guessennd-Kouadio1, 7 and Mireille Dosso1

1Institut Pasteur de Côte d’Ivoire

2Biological Resource Center, Institut Pasteur de Côte d’Ivoire

3Environment And Health Department, Institut Pasteur de Côte d’Ivoire

4Department of Epidemic Viruses, Institut Pasteur de Côte d’Ivoire

5Nangui-Abrogoua University in Abidjan, Côte d’Ivoire

6Department of Epidemiology and Clinical Research, Institut Pasteur de Côte d’Ivoire

7Antibiotics and Natural Substances Unit, Institut Pasteur de Côte d’Ivoire

Pub. Date: September 19, 2023

Cite this paper

Maxime Kouao Diané, Claude Aimée Diaha-Kouamé, Rita José Julie Bouagnon, Hervé A. Kadjo, Karidja Yakoura Ouattara, Mathias Kouamé N’dri, Nathalie Aya Guessennd-Kouadio and Mireille Dosso. Status Report of National Reference Laboratories for Epidemiological Surveillance of Communicable Diseases and Diseases with Epidemic Potential in Côte d'Ivoire after More Than a Decade of Existence. American Journal of Public Health Research. 2023; 11(4):143-151. doi: 10.12691/AJPHR-11-4-3

Abstract

Introduction: Many hospital, public health and university medical laboratories, whether public or private, contribute through their diagnostic activities to health care and the improvement of public health Objective: To evaluate the state of knowledge of the National Reference Centres (NRC) in order to identify measures for their improvement after more than a decade of practice. Method: A cross-sectional study was carried out with managers of national reference laboratories. Result: The NRCs are active in the surveillance of priority communicable diseases. Their activities are national and international in scope. The NRCs are headed by medical doctors or scientific biologists, all of whom are researchers with an experience of 18.4±9.2 years, with 8 (72.7%) men and 3 (27.3%) women. These managers were appointed by a decision of the management. The NRCs estimated the funds allocated to their activities to be (91.7%) insufficient. The NRCs did not have a laboratory information management system (66.7%). Concerning the problem of infrastructure and operational equipment, the result shows that the NRCs are confronted with an interruption of electricity in 16.6% of cases. Half of the NRCs (58.4%) do not have sufficient laboratory space to carry out their work without compromising the quality of work and the safety of staff. 9 (75%) of the NRCs have successfully participated in proficiency testing programmes and 4 (33.3%) have organised proficiency tests. Conclusion: No national reference laboratory is accredited ISO 15189. The results of the assessment can be used to develop a work plan to improve laboratory surveillance and detection of communicable and potentially epidemic diseases in Côte d'Ivoire.

Keywords

national reference center, epidemiological surveillance, communicable diseases, evaluation, Côte d'Ivoire

Copyright

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]  C. A. Petti, C. R. Polage, T. C. Quinn, A. R. Ronald, et M. A. Sande, « Laboratory medicine in Africa: a barrier to effective health care », Clinical Infectious Diseases, vol. 42, no 3, p. 377‑382, 2006.
 
[2]  A. Ogee-Nwankwo et al., « Assessment of National Public Health and Reference Laboratory, Accra, Ghana, within Framework of Global Health Security », Emerg Infect Dis, vol. 23, no Suppl 1, p. S121‑S125, déc. 2017.
 
[3]  World Health Organization, International health regulations (2005). World Health Organization, 2008.
 
[4]  D. Egger, P. Travis, D. Dovlo, L. Hawken, et W. H. Organization, « Strengthening management in low-income countries », World Health Organization, 2005.
 
[5]  M. K. Njenga et al., « Laboratory Epidemiologist: Skilled Partner in Field Epidemiology and Disease Surveillance in Kenya », Journal of Public Health Policy, vol. 29, no 2, p. 149‑164, 2008.
 
[6]  P. Nsubuga et al., « Field Epidemiology and Laboratory Training Programs in sub-Saharan Africa from 2004 to 2010: need, the process, and prospects », Pan African Medical Journal, vol. 10, 2011.
 
[7]  K. Yao et al., « Improving quality management systems of laboratories in developing countries: An innovative training approach to accelerate laboratory accreditation », American journal of clinical pathology, vol. 134, no 3, p. 401‑409, 2010.
 
[8]  S. Kahn et V. Saraiva, « Tool for the evaluation of performance of veterinary services (OIE PVS tool). », in Modernising veterinary legislation for good governance. Proceedings of the OIE Global Conference on Veterinary Legislation, Djerba, Tunisia, 7-9 December 2010, OIE (World Organisation for Animal Health), 2013, p. 67‑71.
 
[9]  G.-M. Gershy-Damet et al., « The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region », Am J Clin Pathol, vol. 134, no 3, p. 393‑400, sept. 2010.
 
[10]  K. Yao, T. Maruta, E. T. Luman, et J. N. Nkengasong, « The SLMTA programme: Transforming the laboratory landscape in developing countries », Afr J Lab Med, vol. 3, no 3, 2014.
 
[11]  A. Diallo et al., « Assessment Tool for Laboratory Services 2017 », USAID Global Health Supply Chain Program, 2017. https://www.ghsupplychain.org/assessment-tool-laboratory-services-2017 (consulté le 28 janvier 2023).
 
[12]  W. H. World Health Organization, « Global measles and rubella strategic plan: 2012 », 2012.
 
[13]  World Health Organization, « Protocol for the assessment of national communicable disease surveillance and response systems: guidelines for assessment teams », World Health Organization, 2001.
 
[14]  W. H. Organization, « Integrated Disease Surveillance Quarterly Bulletin », 2016.
 
[15]  MSHP et MESRS, Arreté interministeriel designant la liste des centres nationaux de reference (CNR) de l’institut pasteur de Côte d’ivoire dans le domaine des maladies transmissibles. 2006, p. 3p.
 
[16]  Y. Sylla, M. K. Diane, V. E. Adjogoua, H. Kadjo, et M. Dosso, « Dengue Outbreaks in Abidjan: Seroprevalence and Cocirculating of Three Serotypes in 2017 », OSIR Journal, vol. 14, no 3, 2021.
 
[17]  kouao M. Diane et al., « Improvement of the Pre-Analytical Phase of Nasopharyngeal Samples During the COVID 19 Pandemic: Experience of the Institute Pasteur De Côte d’Ivoire in 2020 », I J Infectious Disea, vol. 2, no 2, p. 1‑6, juin 2021.
 
[18]  D. K. Odegue et al., « Nasopharyngeal Samples Management Strategy During the COVID-19 Pandemic: Experience of the Pasteur Institute of Côte d’Ivoire (2020) », JSRR, vol. 27, no 4, p. 72‑79, juin 2021.
 
[19]  K. K. Bernadin et al., « Enquête sur le niveau de connaissance des plantes médicinales utilisées contre la maladie à Coronavirus, la grippe et le rhume auprès des voyageurs venus pour le test COVID-19 à l’Institut Pasteur de Côte d’Ivoire », Journal of Applied Biosciences, vol. 168, p. 17456‑17467, 2021.
 
[20]  N. Gumede et al., « Polio Eradication Initiative (PEI) contribution in strengthening public health laboratories systems in the African region », Vaccine, vol. 34, no 43, p. 5164‑5169, oct. 2016.
 
[21]  World Health Organization, « Laboratory Assessment Tool », studylib.net, 2012. https://studylib.net/doc/8793564/laboratory-assessment-tool---world-health-organization (consulté le 25 juillet 2022).
 
[22]  CDC, « Laboratory Assessment Tool_5.0 ». https://www.cdc.gov/hai/pdfs/tap/CDI-Laboratory-Assessment-Tool-v5-508.pdf (consulté le 23 février 2023).
 
[23]  « LEI_2013Jun_Informatics-Self-Assessment-Tool-for-PHLs.pdf ». Consulté le: 23 février 2023. [En ligne]. Disponible sur: https://www.aphl.org/programs/informatics/Documents/LEI_2013Jun_Informatics-Self-Assessment-Tool-for-PHLs.pdf
 
[24]  R. A. Audu et al., « Improving quality in national reference laboratories: The role of SLMTA and mentorship », Afr J Lab Med, vol. 3, no 2, p. 200, sept. 2014.
 
[25]  Assemblee nationale Côte d’Ivoire, Loi 2013-866 du 23 decembre 2013 relative à la normalisation et à la promotion de la qualité. 2013, p. 8. Consulté le: 11 août 2023. [En ligne]. Disponible sur: https://www.juriafrica.com/lex/loi-2013-866-30953.htm
 
[26]  MINISTÈRE DES AFFAIRES SOCIALES ET DE LA SANTÉ, Décret no 2016-1430 du 24 octobre 2016 relatif aux modalités d’accréditation des laboratoires de biologie médicale. 2016, p. 1. Consulté le: 11 août 2023. [En ligne]. Disponible sur: https://www.legifrance.gouv.fr/download/pdf?id=DE6r2sCF670nqSB84oiWUGzksSs0uPNs9BC9diJyZ1o=.
 
[27]  Assemblee nationale France, LOI no 2013-442 du 30 mai 2013 portant réforme de la biologie médicale portant réforme de la biologie médicale. 2013, p. 8. Consulté le: 11 août 2023. [En ligne]. Disponible sur: https://www.legifrance.gouv.fr/download/pdf?id=-ZWGCab_Kc6fUe1izLNANYiX_erjixoTD_Jy3AVXRFk=
 
[28]  C. Nsanzabana, D. Djalle, P. J. Guérin, D. Ménard, et I. J. González, « Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape », Malar J, vol. 17, no 1, p. 75, févr. 2018.
 
[29]  D. Featherstone, D. Brown, et R. Sanders, « Development of the global measles laboratory network », Journal of Infectious Diseases, vol. 187, no Supplement_1, p. S264‑S269, 2003.
 
[30]  M. N. Mulders et al., « Global measles and rubella laboratory network support for elimination goals, 2010–2015 », Morbidity and Mortality Weekly Report, vol. 65, no 17, p. 438‑442, 2016.
 
[31]  World Health Organization, « Global measles and rubella laboratory network support for elimination goals, 2010–2015 », Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire, vol. 91, no 18, p. 240‑246, 2016.
 
[32]  R. G. Jones, O. A. Johnson, et G. Batstone, « Informatics and the Clinical Laboratory », Clin Biochem Rev, vol. 35, no 3, p. 177‑192, août 2014.
 
[33]  L. M. Parsons et al., « Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and Opportunities », Clinical Microbiology Reviews, vol. 24, no 2, p. 314‑350, avr. 2011.
 
[34]  « IDSR-Technical -Guidelines-2010_French _final.pdf ». Consulté le: 5 février 2023. [En ligne]. Disponible sur: https://www.afro.who.int/sites/default/files/2017-06/IDSR-Technical%20-Guidelines-2010_French%20_final.pdf
 
[35]  WHO, « Checklist and indicators for monitoring progress in the development of IHR core capacities in states parties, April 2013 », 2013. https://www.who.int/publications-detail-redirect/who-hse-gcr-2013-2 (consulté le 25 juillet 2022).